SGS Enhances Analytical Solutions with Launch of GMP Compliant NMR Testing for Pharma Industry

SGS Enhances Analytical Solutions with Launch of GMP Compliant NMR Testing for Pharma Industry

(IN BRIEF) SGS has introduced GMP-compliant NMR testing capabilities in China using a JEOL 400 MHz system, strengthening its pharmaceutical analytical services with advanced structural and quantitative analysis. The new offering supports the entire drug development and manufacturing lifecycle by enabling precise identification of active ingredients, detection of impurities, polymorphism analysis, and accurate purity measurement through quantitative NMR. Operating under fully validated GMP conditions, the service ensures regulatory compliance and data integrity while providing high-throughput, non-destructive testing suitable for routine quality control and product validation. This expansion enhances SGS’s ability to support pharmaceutical companies in maintaining high standards of product quality, safety, and compliance in an increasingly regulated global market.

(PRESS RELEASE) BAAR, 29-Apr-2026 — /EuropaWire/ — SGS has expanded its pharmaceutical testing capabilities in China with the introduction of GMP-compliant nuclear magnetic resonance (NMR) testing using a JEOL 400 MHz system. This new service enhances the company’s analytical offering by providing advanced structural analysis and highly accurate quantitative measurements to support pharmaceutical quality control and development processes.

The addition of NMR testing enables deeper molecular insight across the entire drug lifecycle, from early-stage research and development through to commercial manufacturing. As a non-destructive analytical technique, NMR complements existing chromatographic and spectroscopic methods, offering high-resolution structural identification and precise quantification to ensure that pharmaceutical products meet stringent standards for identity, purity, and quality.

The technology supports a wide range of applications critical to the pharmaceutical industry. These include confirming the structure and stereochemistry of active pharmaceutical ingredients, detecting and characterizing impurities and degradation products at very low concentrations, analyzing polymorphism to distinguish between different crystal forms, and performing quantitative NMR to deliver traceable and highly accurate purity assessments linked to international measurement standards.

All testing services are conducted in full compliance with good manufacturing practice requirements, supported by validated procedures and robust quality systems. This includes installation, operational, and performance qualifications, as well as strict data integrity controls and comprehensive personnel training programs, ensuring reliability and regulatory acceptance of results.

The new NMR capability is designed to deliver efficient, high-throughput analysis, making it suitable for routine quality control, identity verification, and purity testing of drug substances, finished products, and raw materials. By integrating this advanced technology into its China operations, SGS aims to provide pharmaceutical manufacturers with cost-effective and compliant solutions that support product safety, regulatory compliance, and overall quality assurance.

Download our technical document.

About SGS

SGS is the world’s leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of over 100,000 dedicated professionals. With more than 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability.

Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and a portfolio of trusted specialized brands, including Applied Technical Services, Brightsight, Bluesign and Nutrasource.

SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN SW).

Media Contact:

Colton Wong
VP Pharma APAC Business
tel:+(86) 21 6064-5089

SOURCE: SGS